Profile data is unavailable for this security.
About the company
Jacobson Pharma Corporation Ltd is an investment holding company principally engaged in the manufacturing and sale of generic drugs. The Company operates its business through two segments. The Generic Drugs segment is engaged in the development, manufacture and distribution of a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment is engaged in the development, manufactures and distributes branded medicines, proprietary Chinese medicines and health and wellness products. Currently the activities of two segments in this regard are primarily carried out in Hong Kong.
- Revenue in HKD (TTM)1.53bn
- Net income in HKD302.58m
- Incorporated2016
- Employees1.79k
- LocationJacobson Pharma Corporation LtdUnit 2313-18, 23/F,Tower 1, Millennium2681 Hong KongHKG
- Phone+852 22672298
- Websitehttps://www.jacobsonpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 1.35bn | 147.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.85 | -- | 24.19 | -- | -- | -- |
| Canbridge Pharmaceuticals Inc | 70.46m | -153.30m | 1.58bn | 45.00 | -- | -- | -- | 22.42 | -0.3609 | -0.3609 | 0.1659 | -1.08 | 0.353 | 1.19 | 3.51 | 1,051,605.00 | -76.80 | -120.49 | -- | -212.95 | 64.40 | 62.24 | -217.58 | -1,040.82 | 0.0371 | -36.43 | -- | -- | -17.27 | 125.21 | -16.84 | -- | -69.90 | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.25bn | 198.75m | 1.79bn | 1.12k | 9.02 | 0.4808 | 6.08 | 1.43 | 0.132 | 0.132 | 0.8325 | 2.48 | 0.2809 | 2.47 | 7.96 | 1,059,921.00 | 4.36 | 10.98 | 5.07 | 13.75 | 45.76 | 55.52 | 15.53 | 32.76 | 4.21 | -- | 0.0028 | 31.01 | -7.89 | 2.22 | 73.29 | 17.20 | 17.13 | 2.69 |
| Zhaoke Ophthalmology Ltd | 39.82m | -313.46m | 1.91bn | 270.00 | -- | 0.9891 | -- | 47.88 | -0.5666 | -0.5666 | 0.0721 | 3.52 | 0.0159 | 1.38 | 9.25 | 135,454.00 | -12.50 | -38.02 | -14.65 | -41.79 | 49.28 | -- | -787.13 | -4,412.89 | 4.36 | -29.83 | 0.1373 | -- | 269.73 | -- | 38.32 | -- | 18.80 | -- |
| Cutia Therapeutics | 281.95m | -531.92m | 1.93bn | 298.00 | -- | 2.00 | -- | 6.83 | -1.69 | -1.69 | 0.8973 | 2.66 | 0.1908 | 2.55 | 5.57 | 846,681.90 | -36.00 | -- | -44.42 | -- | 34.92 | -- | -188.66 | -- | 2.92 | -- | 0.2774 | -- | 103.17 | -- | 77.91 | -- | -- | -- |
| Jbm (Healthcare) Ltd | 812.98m | 216.39m | 2.17bn | 412.00 | 9.93 | 2.01 | 7.82 | 2.67 | 0.2657 | 0.2657 | 0.9984 | 1.31 | 0.5111 | 3.76 | 5.05 | 2,913,918.00 | 14.09 | 6.57 | 17.00 | 7.83 | 56.76 | 47.82 | 27.56 | 16.60 | 2.41 | -- | 0.2486 | 53.40 | 20.65 | 15.44 | 51.20 | 36.90 | 35.96 | -- |
| SinoMab Bioscience Ltd | 0.00 | -162.57m | 2.32bn | 61.00 | -- | 7.34 | -- | -- | -0.1502 | -0.1502 | 0.00 | 0.2275 | 0.00 | -- | -- | 0.00 | -18.46 | -22.26 | -24.62 | -25.68 | -- | -- | -- | -3,832.94 | -- | -7.82 | 0.6265 | -- | 48.42 | -- | 23.85 | -- | -0.376 | -- |
| Essex Bio-Technology Ltd | 1.73bn | 313.18m | 2.36bn | 1.43k | 7.55 | 1.04 | 6.36 | 1.36 | 0.5508 | 0.5508 | 3.05 | 4.01 | 0.5596 | 2.96 | 2.84 | 1,196,360.00 | 10.10 | 10.28 | 13.56 | 13.62 | 89.50 | 87.73 | 18.05 | 18.70 | 1.82 | -- | 0.1135 | 17.49 | -3.87 | 5.47 | 11.61 | 0.3101 | -7.47 | 7.14 |
| Golden Throat Holdings Group Co Ltd | 1.10bn | 301.97m | 2.37bn | 842.00 | 7.83 | 1.74 | 6.97 | 2.14 | 0.4085 | 0.4085 | 1.49 | 1.84 | 0.467 | 2.29 | 5.32 | 1,262,519.00 | 12.78 | 11.71 | 21.02 | 16.75 | 76.42 | 73.08 | 27.37 | 25.87 | 1.73 | 21.95 | 0.3616 | 94.67 | 23.26 | 8.25 | 27.37 | 13.71 | -12.27 | 34.38 |
| Hangzhou Jiuyuan Genetic Biopharm Co Ltd | 1.47bn | 139.02m | 2.43bn | 1.63k | 15.59 | 1.37 | 13.09 | 1.65 | 0.6436 | 0.6436 | 7.20 | 7.33 | 0.7509 | 1.55 | 2.17 | 954,244.80 | 7.10 | -- | 8.88 | -- | 81.67 | -- | 9.45 | -- | 4.03 | 46.31 | 0.1058 | -- | 6.35 | -- | 15.72 | -- | -- | -- |
| Jacobson Pharma Corporation Ltd | 1.53bn | 302.58m | 2.50bn | 1.79k | 8.23 | 1.12 | 5.54 | 1.63 | 0.1519 | 0.1519 | 0.7698 | 1.12 | 0.4299 | 2.54 | 9.06 | 876,757.00 | 8.48 | 4.83 | 10.29 | 6.17 | 44.30 | 41.26 | 19.73 | 14.85 | 0.9023 | 10.21 | 0.286 | 57.09 | 7.43 | 0.0691 | 43.09 | 7.05 | 24.09 | 14.87 |
Data as of Feb 06 2026. Currency figures normalised to Jacobson Pharma Corporation Ltd's reporting currency: Hong Kong Dollar HKD
0.32%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 4.62m | 0.23% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 1.08m | 0.05% |
| Lazard Asset Management LLCas of 31 Dec 2025 | 232.00k | 0.01% |
| Baillie Gifford & Co.as of 28 Nov 2025 | 208.80k | 0.01% |
| Bessemer Investment Management LLCas of 31 Oct 2025 | 205.92k | 0.01% |
| DFA Australia Ltd.as of 30 Nov 2025 | 91.59k | 0.01% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
